Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Amarin Stock Lost 13.4% in January

TheMotleyFool

0 0

Shares of Amarin (NASDAQ: AMRN), a mid-cap drugmaker, dropped by 13.4% last month, according to data from S&P Global Market Intelligence. Shares took a beating in January for two reasons:

First, Amarin has long been rumored to be a top buyout candidate. A worthwhile tender offer has yet to materialize, however. As a result, investors looking for a quick buck on a high-priced buyout appear to be moving on to greener pastures.

Second, nearly all biotech stocks took a sizable downturn toward the tail end of January due to the growing concerns over the Wuhan coronavirus. The core reason is that this emerging viral pandemic is now expected to have a profound effect on the global economy in 2020.

Source Fool.com

Like: 0

AMRN

Share